ZeroStack Corp. 1Q 2026: Revenue $7.27M, EPS $(3.68) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.ZeroStack Corp. reported Q1 2026 revenue of $7.27M, a 5.9% increase from $6.87M in Q1 2025. The company faced a net loss of $(36.66) M and a diluted EPS of $(3.68). Revenue growth was attributed to Phatebo pharmaceutical sales and $2.8M from staking rewards. ZeroStack is focusing on digital-asset staking as a core revenue stream and has taken steps to regain Nasdaq compliance by appointing independent directors and rebuilding committees.
ZeroStack Corp. reported first-quarter 2026 results with revenue of $7.27M, up 5.9% from $6.87M a year earlier, while the company recorded a net loss of $(36.66) M and diluted loss per share of $(3.68) for the quarter.
Financial Highlights
- Revenue: $7.274M for Q1 2026, up from $6.866M in Q1 2025 (5.9% YoY).
- Net income: Net loss of $(36.660) M for Q1 2026 versus net loss of $(0.758) M in Q1 2025.
- Diluted EPS: $(3.68) for Q1 2026 versus $(1.54) in Q1 2025.
Business Highlights
- Revenue growth was driven by Phatebo pharmaceutical sales and approximately $2.8M of staking rewards recognized after the company began staking 0G Tokens on Jan. 21, 2026.
- ZeroStack has shifted part of its go-to-market mix to include digital-asset staking as a core revenue stream following completed PIPE and token financings and material 0G token contributions.
- Phatebo continues global pharmaceutical distribution across 28 countries and supports EU logistics operations.
- Corporate governance steps to regain Nasdaq compliance included appointing independent directors and rebuilding key committees.
Original SEC Filing: ZeroStack Corp. [ ZSTK ] - 10-Q - May. 01, 2026